A national analysis of systemic adverse events of beta-blockers used for glaucoma therapy.
Owais M AftabHamza KhanRoshun SanganiAlbert S KhouriPublished in: Cutaneous and ocular toxicology (2024)
β-blocker use in glaucoma therapy can be rarely associated with serious systemic and life-threatening complications.